Corcept Therapeutics
CORT
#2076
Rank
NZ$12.27 B
Marketcap
$116.37
Share price
7.10%
Change (1 day)
208.98%
Change (1 year)

P/S ratio for Corcept Therapeutics (CORT)

P/S ratio as of April 2025 (TTM): 10.8

According to Corcept Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 10.8. At the end of 2024 the company had a P/S ratio of 8.14.

P/S ratio history for Corcept Therapeutics from 2007 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20248.1417.34%
20236.9427.57%
20225.44-12.9%
20216.25-27.27%
20208.5989.9%
20194.52-26.07%
20186.12-52.75%
201712.930.61%
20169.91-8.71%
201510.9-5.22%
201411.5-62.98%
201330.9-28.3%
201243.2
2011N/A
2010N/A-100%
2009> 10006549.54%
200887.1-60.46%
2007220

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.22-61.06%๐Ÿ‡บ๐Ÿ‡ธ USA
2.04-81.12%๐Ÿ‡บ๐Ÿ‡ธ USA
4.23-60.93%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
16.5 52.74%๐Ÿ‡บ๐Ÿ‡ธ USA
2.00-81.57%๐Ÿ‡บ๐Ÿ‡ธ USA
3.09-71.48%๐Ÿ‡บ๐Ÿ‡ธ USA
0.5660-94.77%๐Ÿ‡บ๐Ÿ‡ธ USA
4.91-54.68%๐Ÿ‡บ๐Ÿ‡ธ USA
4.16-61.56%๐Ÿ‡บ๐Ÿ‡ธ USA